We want to discover
novel molecular mechanisms involved in human diseases. Understanding
these mechanisms might pave the way to novel therapies in cancer and
achieve this, we use a wide array of methods in molecular biology,
genetics, biochemistry and mass spectrometry. While we are particularly
interested in metabolic changes in cancer, we are open to serendipitous
discoveries on the way (e.g. the recent discovery of
ribitolphosphorylation as a novel posttranslational modification).